Abstract:Background: An increasing amount of data are being published which risk-stratify thyroid tumors according to genetic signatures and histologic morphology. Typically, follicular patterned lesions have been shown to harbor RAS-like mutations with more indolent behaviors. Our study aims to examine the extent of similarity amongst three groups of follicular patterned lesions with papillary nuclear features--noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), encapsulated follicular variant of papillary thyroid carcinoma (EFVPTC) with capsular and/or angioinvasion and infiltrative follicular variant of papillary thyroid carcinoma (iFVPTC)--in order to help clarify whether NIFTP and EFVPTC represent a histologic continuum and the degree to which the genomic landscape further separates higher risk follicular patterned tumors like iFVPTC from more indolent ones (EFVPTC and NIFTP). Methods: ThyroSeq test results were compared for cases with histologic NIFTP, EFVPTC and iFVPTC in this retrospective study. Genetic drivers were subcategorized by level of aggressiveness. Gene expression alterations (GEAs) and copy number alterations (CNAs) were compared amongst the three histologic groups. Results: NIFTP and EFVPTC cases displayed predominantly RAS-like alterations (100% and 75% respectively) and RAS-like GEAs (55.2% and 47.2%), and many showed CNAs with 22q-loss. Despite a predominance of RAS-like alterations, EFVPTC cases showed molecular heterogeneity with significantly more intermediate and aggressive drivers (22.3% of cases) than NIFTP (0%), p= 0.0068. iFVPTC cases displayed molecular profiles in between that of traditional follicular patterned lesions and classical papillary thyroid carcinoma, predominantly displaying intermediate and aggressive drivers (61.6%), which was significantly higher than that of EFVPTC (22.3%, p=0.0158) and NIFTP (0%, p<0.0001), illustrating the higher MAP-Kinase activity of iFVPTC. There was no significant difference however in comparing GEAs amongst the three histologic groups. Conclusions: While follicular patterned lesions with papillary nuclear features overall tend to display RAS-like alterations, EFVPTC cases, followed by iFVPTC in this series showed increasing proportions of more aggressive drivers. EFVPTC and NIFTP show much molecular overlap, with predominance of RAS-like alterations, suggesting that these tumors are part of a genetic continuum, while still ranked differentially. Preoperative molecular testing can potentially distinguish EFVPTC and iFVTPC from NIFTP based on a particular molecular signature, optimizing patient management.

Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Diagnosis and Differential Diagnoses

Advances in Diagnosis and Treatment of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Clinical and Sonographic Features of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): what do we need to know?

Is Conservative Management of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP) Possible in Children?

Molecular Profile and Clinicopathologic Features of Follicular Variant Papillary Thyroid Carcinoma

Study of non-invasive follicular thyroid neoplasm: A borderline entity

Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and the Practice in Qilu Hospital of Shandong University, China

Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents

Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma

Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma

Nodal metastasis in noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)

Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?

Molecular Profiles of Non-Invasive, Minimally Invasive and Invasive Follicular Patterned Thyroid Neoplasms with Papillary Nuclear Features

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) in Mureș County, Romania: Incidence and impact of reclassification over a six-year period (2016-2021)

Nuclear CK19-immunopositive pseudoinclusions as a new additional objective diagnostic feature of papillary thyroid carcinoma

NIFTP-adjusted risk estimation of Bethesda thyroid cytology categories should consider the indication for FNA according to TIRADS

HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions

Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs)

How many papillae in conventional papillary carcinoma?

RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists